Last10K.com

Accentia Biopharmaceuticals Inc (1310094) SEC Filing 8-K Material Event for the period ending Wednesday, February 20, 2013

Accentia Biopharmaceuticals Inc

HISTORY TOOLS
CIK: 1310094

View differences made from one to another to evaluate Accentia Biopharmaceuticals Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Accentia Biopharmaceuticals Inc.

Continue

Assess how Accentia Biopharmaceuticals Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Accentia Biopharmaceuticals Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2013 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
CIK: 1310094
Form Type: 8-K Corporate News
Accession Number: 0001214659-13-000986
Submitted to the SEC: Fri Feb 22 2013 4:24:05 PM EST
Accepted by the SEC: Fri Feb 22 2013
Period: Wednesday, February 20, 2013
Industry: Pharmaceutical Preparations
Events:
  1. Event for Officers

External Resources:
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/1310094/0001214659-13-000986.htm